human cell

Octapharma announces FDA approval of updated NUWIQ® Prescribing Information to include immunogenicity data in previously untreated patients

LACHEN, Switzerland:  Octapharma is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved an updated Prescribing…

Read More »